STOCK TITAN

Baszucki and Trust sell 8,333 shares each (RBLX)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

The issuer RBLX submitted a Form 144 disclosing Rule 144/10b5-1 sales by reporting persons. The excerpt lists 10b5-1 sales on 02/27/2026 and 04/01/2026 by Greg Baszucki and the Greg and Christina Baszucki Living Trust, each showing 8,333 shares and proceeds per entry of $574,817.01 (02/27/2026) and $482,920.68 (04/01/2026).

Positive

  • None.

Negative

  • None.

Insights

Form 144 lists multiple 10b5-1 dispositions by the Baszucki parties.

The filing records sales executed under 10b5-1 plans on 02/27/2026 and 04/01/2026 by Greg Baszucki and an affiliated trust, each line showing 8,333 shares and stated proceeds per line. This is a routine disclosure of securities dispositions under Section 144/10b5-1 procedures.

Cash‑flow treatment and aggregate totals across holders are not provided in the excerpt; subsequent filings or broker confirmations would show aggregate proceeds and any remaining planned activity.

Shares per listed sale 8,333 shares per 10b5-1 sale line (02/27/2026 and 04/01/2026)
Proceeds (02/27/2026) $574,817.01 per listed sale line dated 02/27/2026
Proceeds (04/01/2026) $482,920.68 per listed sale line dated 04/01/2026
Form type Form 144 Rule 144/10b5-1 disclosure
10b5-1 regulatory
"10b5-1 Sales for GREG BASZUCKI 3150 South Delaware"
A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.
Founders Shares market
"Common | 09/21/2016 | Founders Shares"
Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.
Issuer regulatory
"Founders Shares | Issuer"

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does RBLX's Form 144 say about Greg Baszucki sales?

The Form 144 shows 10b5-1 sales by Greg Baszucki on 02/27/2026 and 04/01/2026. Each listed sale is for 8,333 shares with proceeds shown as $574,817.01 (02/27) and $482,920.68 (04/01).

Did the Greg and Christina Baszucki Living Trust also sell shares in the filing?

Yes. The excerpt lists matching 10b5-1 sales attributed to the Greg and Christina Baszucki Living Trust on the same dates, each showing 8,333 shares and the same per-entry proceeds figures as the individual filings.

Are the sales in the Form 144 described as 10b5-1 plan transactions?

The entries are labeled as 10b5-1 Sales, indicating the transactions were effected pursuant to 10b5-1 plans as reported in the excerpt. The document lists dates, share counts, and proceeds for each line item.

Does the Form 144 excerpt state aggregate totals or who received proceeds?

The excerpt provides per‑line proceeds amounts ($574,817.01 and $482,920.68) but does not state an aggregate total or explicitly name the payee of proceeds beyond the reporting persons shown.